Back to Search Start Over

Blastoid variant of mantle cell lymphoma in palatine tonsil.

Authors :
Valente VB
de Castro TF
Takamiya AS
Callestini R
Xavier-Junior JCC
Cortopassi GM
Neto SC
Collado FU
Biasoli ÉR
Miyahara GI
Bernabé DG
Source :
Oral oncology [Oral Oncol] 2021 Nov; Vol. 122, pp. 105552. Date of Electronic Publication: 2021 Oct 02.
Publication Year :
2021

Abstract

Blastoid variant of mantle cell lymphoma (MCL) is an aggressive and extremely rare malignancy. MCL may be diagnosed in lymph nodes and/or extranodal sites exhibiting a poor prognosis. MCL with primary presentation in palatine tonsils has been rarely reported. Herein, we report the case of a 73-year-old man with a painless nodular mass on the right palatine tonsil. A biopsy was performed, and microscopic analysis revealed a neoplasm composed of small to medium sized lymphocytes with finely dispersed chromatin, roundish nucleus and many mitoses. The tumor cells were positive for CD20 (L26), CD5 (4C7), Cyclin D1 (EP12), Bcl2 (124) and Ki-67 (MIB-1; 90%), and negative for Bcl6 (PG-B6p), MUM1 (MUM1p) and CD3 (Polyclonal). These findings led to the diagnosis of blastoid variant of MCL. Diagnostic workup with computed tomography scan excluded other sites of disease. The patient was treated successfully with cyclophosphamide, doxorubicin, vincristine and prednisolone (mini-CHOP regimen). Although the blastoid variant of MCL is rare, it should be included in the differential diagnosis of rapid-growing masses in the palatine tonsil.<br /> (Copyright © 2021. Published by Elsevier Ltd.)

Details

Language :
English
ISSN :
1879-0593
Volume :
122
Database :
MEDLINE
Journal :
Oral oncology
Publication Type :
Report
Accession number :
34610523
Full Text :
https://doi.org/10.1016/j.oraloncology.2021.105552